Century Therapeutics, Inc.IPSCNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank96
3Y CAGR+89.1%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
+89.1%/yr
Quarterly compound
Percentile
P96
Near historical high
vs 3Y Ago
6.8x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 37.16% |
| Q3 2025 | 7.28% |
| Q2 2025 | 20.31% |
| Q1 2025 | -42.93% |
| Q4 2024 | 14.50% |
| Q3 2024 | -3.66% |
| Q2 2024 | 9.64% |
| Q1 2024 | -15.32% |
| Q4 2023 | -92.18% |
| Q3 2023 | 29.10% |
| Q2 2023 | 34.12% |
| Q1 2023 | -27.55% |
| Q4 2022 | 5.50% |
| Q3 2022 | 5.15% |
| Q2 2022 | -129.46% |
| Q1 2022 | 456.26% |
| Q4 2021 | -1.53% |
| Q3 2021 | -29.71% |
| Q2 2021 | 16.64% |
| Q1 2021 | -67.77% |
| Q4 2020 | -43.31% |
| Q3 2020 | 22.74% |
| Q2 2020 | -73.45% |
| Q1 2020 | 0.00% |